Can SGLT2 and GLP1 Agents Be Cost-Effective First-Line Treatments for Diabetes?
Researchers evaluate the lifetime cost-effectiveness of using SGLT2 inhibitors or GLP1 receptor agonists as first-line treatments for type 2 diabetes.
Type 2 Diabetes
Maintaining Weight Loss After Intensive Lifestyle Intervention and Lower CV Risk in Type 2 Diabetes
Researchers sought to determine if the CV effect of intensive lifestyle intervention varies depending on if patient’s can maintain weight loss after the initial intervention.
Obesity in Adolescence Linked to Type 1 Diabetes in Adulthood
Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.
Obesity-Associated Microvascular and Macrovascular Complications Among Patients With Diabetes
Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.
Maintenance of Intermittent Fasting for Weight Loss and Metabolic Health Improvements
A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.
Excessive Body Weight Change Linked to Increased Risk of Cardiovascular Events in Type 2 Diabetes
Investigators sought to determine if an association existed between weight change and major cardiovascular outcomes among patients with type 2 diabetes.
FDA Clears Smartphone App for Insulin Delivery
The updated t:connect mobile app is the first-ever FDA-cleared smartphone application capable of initiating insulin delivery via iOS and Android operating systems.
Semaglutide Linked With Better Outcomes vs Dulaglutide in Type 2 Diabetes
Researchers conducted an indirect treatment comparison of semaglutide 2.0 mg with dulaglutide 3.0 mg or 4.5 mg to observe which was superior in lowering HbA1c and body weight in people with type 2 diabetes.
Maximum BMI Predicts Advanced Diabetic Complications Before T2D Onset
Investigators evaluated whether maximum body mass index before onset of type 2 diabetes could predict progressive diabetic retinopathy or diabetic nephropathy in patients with type 2 diabetes.
Impact of Physical Activity on Cardiometabolic Risk in Type 2 Diabetes
Exercise helps cardiovascular and other physical and clinical outcomes in type 2 diabetes, but the amount and intensity of the exercise needed to make a difference is debated.
- Loading...
Loading...
Next post in Cardiology
Loading... 
Loading...